Related Experiment Video
Updated: Dec 23, 2025

Amplification of Near Full-length HIV-1 Proviruses for Next-Generation Sequencing
Published on: October 16, 2018
HIV-1 DNA decay dynamics in early treated individuals: practical considerations for clinical trial design
Ángel Bayón-Gil1, Maria C Puertas1, Víctor Urrea1
1IrsiCaixa AIDS Research Institute, Badalona, Spain.
Background:
Initiation of combination antiretroviral therapy (cART) soon after HIV-1 infection limits the establishment of viral reservoirs. Thus, early treated individuals are preferred candidates to evaluate novel viral remission strategies. However, their cART-dependent HIV-1 DNA decay dynamics are still poorly defined. This can hamper the design and interpretation of results from clinical trials intended to further reduce viral reservoirs.
Objectives:
To clarify the duration of cART needed for the HIV-1 reservoir to be stabilized in early treated individuals.
Methods:
We characterized the longitudinal decline of total HIV-1 DNA levels by droplet digital PCR in 21 individuals initiating cART within 6 months after estimated HIV-1 acquisition. Measurements were taken at cART initiation, after 6 months and annually until Year 4. Correlations between virological and clinical parameters were statistically analysed. Statistical modelling was performed applying a mixed-effects model.
Results:
Total HIV-1 DNA experienced a median overall decrease of 1.43 log10 units (IQR = 1.17-1.69) throughout the 4 years of follow-up. Baseline levels for total HIV-1 DNA, viral load, absolute CD4+ T cell count and CD4+/CD8+ ratio correlate with final HIV-1 DNA measurements (R2 = 0.68, P < 0.001; R2 = 0.54, P = 0.012; R2 = -0.47, P = 0.031; and R2 = -0.59, P = 0.0046, respectively). Statistical modelling shows that after 2 years on cART the viral reservoir had reached a set point.
Conclusions:
A waiting period of 2 years on cART should be considered when designing interventions aiming to impact latent HIV-1 reservoir levels and viral rebound kinetics after cART discontinuation, in order to facilitate interpretation of results and enhance the chance of viral control.
Insights
Early combination antiretroviral therapy (cART) for HIV-1 infection leads to viral reservoir stabilization after two years. This finding is crucial for designing effective viral remission strategies and interpreting clinical trial outcomes in HIV-1 management.
Area of Science:
- Virology
- Immunology
- Infectious Diseases
Background:
- Early initiation of combination antiretroviral therapy (cART) for HIV-1 infection is key to limiting viral reservoir establishment.
- Understanding HIV-1 DNA decay dynamics in early-treated individuals is essential for developing novel viral remission strategies.
- Poorly defined decay dynamics can hinder the design and interpretation of clinical trials targeting HIV-1 reservoirs.
Purpose of the Study:
- To determine the necessary duration of cART for stabilizing the HIV-1 reservoir in individuals treated early after infection.
- To clarify the kinetics of HIV-1 DNA decay under cART in a cohort of early-treated patients.
Main Methods:
- Longitudinal analysis of total HIV-1 DNA levels using droplet digital PCR in 21 individuals initiating cART within 6 months of infection.
- Measurements were collected at cART initiation, 6 months, and annually up to Year 4.
- Statistical modeling, including mixed-effects models, was used to analyze correlations between virological and clinical parameters.
Main Results:
- Total HIV-1 DNA showed a median decrease of 1.43 log10 units over 4 years of follow-up.
- Baseline HIV-1 DNA, viral load, CD4+ T cell count, and CD4+/CD8+ ratio significantly correlated with final HIV-1 DNA levels.
- Statistical modeling indicated that the viral reservoir reached a stable set point after 2 years on cART.
Conclusions:
- A 2-year treatment period with cART should be considered when designing interventions aimed at reducing latent HIV-1 reservoirs.
- This waiting period is important for interpreting results from studies on viral rebound kinetics after cART discontinuation.
- Considering this stabilization period enhances the potential for achieving sustained viral control in HIV-1 remission strategies.
More Related Videos
13:58Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays
Published on: September 26, 2011
07:18High Throughput In Vitro Assessment of Latency Reversing Agents on HIV Transcription and Splicing
Published on: January 22, 2019
Related Concept Videos
Retrovirus Life Cycles
Size and Structure of Viral Genomes